IL-18 polymorphisms in hepatitis B virus related liver disease

Cytokine

Volumn 73, Issue 2, 2015, Pages 277-282

  Karra, Vijay Kumar ^a   Gumma, Phani Kumar ^a   Chowdhury, Soumya Jyoti ^a   Ruttala, Rajesh ^a   Polipalli, Sunil Kumar ^a   Chakravarti, Anita ^a   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Hepatitis B; Interleukine 18 (IL 18); Single nucleotide polymorphism (SNP)

Indexed keywords

INTERLEUKIN 18;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; IL 18 GENE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; CASE CONTROL STUDY; DEMOGRAPHY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HEPATITIS B VIRUS; PHYSIOLOGY; VIROLOGY;

HEPATITIS B VIRUS;

ADULT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-18; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84925296604     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.02.015     Document Type: Article

References (41)

1. Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002, 62(Suppl 1):18-23.
2. Lok A.S.F., McMahon B.J. Chronic hepatitis B. Hepatol Baltimore Md 2007, 45(2):507-539.
3. Gupta S., Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol WJG 2006, 12(42):6879-6883.
4. Bhattacharya P., Chandra P.-K., Datta S., Banerjee A., Chakraborty S., Rajendran K., et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol WJG 2007, 13(27):3730-3733.
5. Shimbo S., Zhang Z.W., Qu J.B., Wang J.J., Zhang C.L., Song L.H., et al. Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong Province, China. Southeast Asian J Trop Med Public Health 1997, 28(3):500-506.
6. Thursz M.R. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat 1997, 4(4):215-220.
7. Bataller R., North K.E., Brenner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatol Baltimore Md 2003, 37(3):493-503.
8. Rapicetta M., Ferrari C., Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol 2002, 67(3):454-457.
9. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284(5415):825-829.
10. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001, 19:423-474.
11. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378(6552):88-91.
12. Kojima H., Aizawa Y., Yanai Y., Nagaoka K., Takeuchi M., Ohta T., et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol Baltimore Md 1950 1999, 162(9):5063-5069.
13. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4(1):25-36.
14. Penna A., Del Prete G., Cavalli A., Bertoletti A., D'Elios M.M., Sorrentino R., et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatol Baltimore Md 1997, 25(4):1022-1027.
15. Zhang P.-A., Wu J.-M., Li Y., Yang X.-S. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol WJG 2005, 11(11):1594-1598.
16. Broderick A.L., Jonas M.M. Hepatitis B in children. Semin Liver Dis 2003, 23(1):59-68.
17. Thio C.L., Thomas D.L., Carrington M. Chronic viral hepatitis and the human genome. Hepatol Baltimore Md 2000, 31(4):819-827.
18. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
19. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatol Baltimore Md 2004, 39(4):978-988.
20. El-Mezzein R.E., Matsumoto T., Nomiyama H., Miike T. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 2001, 126(2):193-198.
21. Higashi N., Gesser B., Kawana S., Thestrup-Pedersen K. Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2001, 108(4):607-614.
22. Kimura K., Kakimi K., Wieland S., Guidotti L.G., Chisari F.V. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002, 76(21):10702-10707.
23. Wei Y.-S., Lan Y., Liu Y.-G., Tang H., Tang R.-G., Wang J.-C. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol Stockh Swed 2007, 46(8):1090-1096.
24. Bouzgarrou N., Hassen E., Schvoerer E., Stoll-Keller F., Bahri O., Gabbouj S., et al. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol 2008, 80(4):607-614.
25. Fouad N.A., Baraka E.A., Hassan W.A. Interleukin-18 gene polymorphisms in systemic lupus erythematosus: relation to disease status. Egypt J Immunol Egypt Assoc Immunol 2014, 21(1):1-12.
26. Gurram V.C., Polipalli S.K., Karra V.K., Puppala M., Pandey S.K., Kapoor S., et al. Genetic polymorphism of interleukin-18 gene promoter region in rheumatoid arthritis patients from southern India. J Clin Diagn Res JCDR 2014, 8(6):SC01-SC04.
27. Hazzaa H.H.A., Rashwan W.A.M., Attia E.A.S. IL-18 gene polymorphisms in aphthous stomatitis vs. Behçet's disease in a cohort of Egyptian patients. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 2014.
28. Back LK D.C., Farias T.D.J., da Cunha P.A., Muniz Y.C.N., Ribeiro M.C.M., Fernandes B.L., et al. Functional polymorphisms of interleukin-18 gene and risk of breast cancer in a Brazilian population. Tissue Antigens 2014, 84(2):229-233.
29. Li H., Xuan M., Xue F., Liu X., Zhang D., Fu R., et al. Absence of association of interleukin-18 gene polymorphisms with primary immune thrombocytopenia in a Chinese Han population. DNA Cell Biol 2014, 33(8):537-542.
30. Karakas Celik S., Öz Z.S., Dursun A., Unal A., Emre U., Cicek S., et al. Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis. Mol Biol Rep 2014, 41(3):1653-1658.
31. Teixeira A.C., Mendes C.T., Marano L.A., Deghaide N.H.S., Secaf M., Elias J., et al. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Hum Immunol 2013, 74(8):1024-1029.
32. Yang Y.-C., Chang T.-Y., Chen T.-C., Chang S.-C., Lin W.-S., Lee Y.-J. Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Hum Immunol 2013, 74(7):882-887.
33. Tavares N.A.C., Santos M.M.S., Moura R., Araújo J., Guimarães R., Crovella S., et al. Interleukin 18 (IL18) gene promoter polymorphisms are associated with type 1 diabetes mellitus in Brazilian patients. Cytokine 2013, 62(2):286-289.
34. Jaiswal P.K., Singh V., Srivastava P., Mittal R.D. Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population. Gene 2013, 519(1):128-134.
35. Wang J., Liu X., Xie J., Xu Y. Association of interleukin-18 promoter polymorphisms with chronic obstructive pulmonary disease in male smokers. Int J Immunogenet 2013, 40(3):204-208.
36. Ksiaa Cheikhrouhou L., Sfar I., Aounallah-Skhiri H., Aouadi H., Jendoubi-Ayed S., Ben Abdallah T., et al. Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. Hepatobiliary Pancreat Dis Int Hbpd Int 2011, 10(3):280-288.
37. Manohar K., Suneetha P.V., Sukriti null, Pati N.T., Gupta A.C., Hissar S., et al. Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatol Int 2009, 3(2):371-377.
38. Castelar L., Silva M.M., Castelli E.C., Deghaide N.H.S., Mendes-Junior C.T., Machado A.A., et al. Interleukin-18 and interferon-gamma polymorphisms in Brazilian human immunodeficiency virus-1-infected patients presenting with lipodystrophy syndrome. Tissue Antigens 2010, 76(2):126-130.
39. Haghshenas M.R., Hosseini S.V., Mahmoudi M., Saberi-Firozi M., Farjadian S., Ghaderi A. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol 2009, 24(6):1119-1122.
40. Samsami Dehaghani A., Shahriary K., Kashef M.A., Naeimi S., Fattahi M.J., Mojtahedi Z., et al. Interleukin-18 gene promoter and serum level in women with ovarian cancer. Mol Biol Rep 2009, 36(8):2393-2397.
41. Giedraitis V., He B., Huang W.X., Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001, 112(1-2):146-152.